RIGL - Rigel Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$27.33
DETAILS
HIGH:
$42.00
LOW:
$2.00
MEDIAN:
$38.00
CONSENSUS:
$27.33
DOWNSIDE:
5.79%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 445,678 | $12.1M | 0.0% | +21,362 | INCREASED |
| Greenblatt | 0 | $0 | -- | -4,805 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-15 | LAPOINTE ANTHONY GREGG | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | Frohlich Mark W | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | Wasman Jane | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | MOOS WALTER H | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | HANNAH ALISON L. | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | Ali-Jackson Kamil | director | A-Award | 5,750 | -- | -- |
| 2026-05-15 | MILLER MICHAEL PATRICK | director | A-Award | 5,750 | -- | -- |
| 2026-02-20 | MOOS WALTER H | director | SELL | 4,000 | $36.36 | $145K |
| 2026-02-20 | MOOS WALTER H | director | M-Exempt | 4,000 | $24.00 | $96K |
| 2026-02-17 | RODRIGUEZ RAUL R | director, officer: CEO, President | A-Award | 53,915 | -- | -- |
| 2026-02-17 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | A-Award | 19,497 | -- | -- |
| 2026-02-17 | Rojkjaer Lisa | officer: EVP, Chief Medical Officer | A-Award | 18,894 | -- | -- |
| 2026-02-17 | Santos David A | officer: EVP, Chief Commercial Officer | A-Award | 19,430 | -- | -- |
| 2026-02-17 | Schorno Dean L | officer: EVP & Chief Financial Officer | A-Award | 20,636 | -- | -- |
| 2026-02-10 | Rojkjaer Lisa | officer: EVP, Chief Medical Officer | F-InKind | 3,758 | $34.62 | $130K |
| 2026-02-10 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | F-InKind | 3,546 | $34.62 | $123K |
| 2026-02-10 | RODRIGUEZ RAUL R | director, officer: CEO, President | F-InKind | 7,607 | $34.62 | $263K |
| 2026-02-10 | Santos David A | officer: EVP, Chief Commercial Officer | F-InKind | 3,546 | $34.62 | $123K |
| 2026-02-10 | Schorno Dean L | officer: EVP & Chief Financial Officer | F-InKind | 3,546 | $34.62 | $123K |
| 2026-02-02 | Schorno Dean L | officer: EVP & Chief Financial Officer | F-InKind | 5,488 | $36.01 | $198K |
| 2026-02-02 | Santos David A | officer: EVP, Chief Commercial Officer | F-InKind | 5,718 | $36.01 | $206K |
| 2026-02-02 | Furey Raymond J. | officer: EVP, GC, CCO & Corp Sec | F-InKind | 3,968 | $36.01 | $143K |
| 2026-01-26 | RODRIGUEZ RAUL R | director, officer: CEO, President | F-InKind | 35,211 | $37.00 | $1.3M |
| 2026-01-26 | RODRIGUEZ RAUL R | director, officer: CEO, President | F-InKind | 35,424 | $37.00 | $1.3M |
| 2026-01-26 | RODRIGUEZ RAUL R | director, officer: CEO, President | M-Exempt | 40,000 | $27.40 | $1.1M |